GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » EV-to-FCF

U2Bio Co (XKRX:221800) EV-to-FCF : -3.27 (As of May. 23, 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, U2Bio Co's Enterprise Value is ₩11,562 Mil. U2Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-3,532 Mil. Therefore, U2Bio Co's EV-to-FCF for today is -3.27.

The historical rank and industry rank for U2Bio Co's EV-to-FCF or its related term are showing as below:

XKRX:221800' s EV-to-FCF Range Over the Past 10 Years
Min: -144.68   Med: -2.12   Max: 501.36
Current: -2.7

During the past 9 years, the highest EV-to-FCF of U2Bio Co was 501.36. The lowest was -144.68. And the median was -2.12.

XKRX:221800's EV-to-FCF is ranked worse than
100% of 95 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.39 vs XKRX:221800: -2.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), U2Bio Co's stock price is ₩4170.00. U2Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩63.000. Therefore, U2Bio Co's PE Ratio for today is 66.19.


U2Bio Co EV-to-FCF Historical Data

The historical data trend for U2Bio Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co EV-to-FCF Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -19.55 18.39 4.85 1.25 -6.58

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
EV-to-FCF - 1.25 - -6.58

Competitive Comparison of U2Bio Co's EV-to-FCF

For the Diagnostics & Research subindustry, U2Bio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where U2Bio Co's EV-to-FCF falls into.



U2Bio Co EV-to-FCF Calculation

U2Bio Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=11562.205/-3532.493
=-3.27

U2Bio Co's current Enterprise Value is ₩11,562 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U2Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-3,532 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U2Bio Co  (XKRX:221800) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

U2Bio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4170.00/63.000
=66.19

U2Bio Co's share price for today is ₩4170.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U2Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩63.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


U2Bio Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of U2Bio Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines